2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 66716647, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12]([CH:14]1[CH2:16][CH2:15]1)=[O:13])=[C:5]2[NH:17][C:18]1[CH:23]=[CH:22][C:21]([CH2:24][N:25]2[CH2:30][CH2:29][N:28]([CH3:31])[CH2:27][CH2:26]2)=[CH:20][CH:19]=1.[Cl:32][C:33]1[CH:38]=[C:37](B2OC(C)(C)C(C)(C)O2)[CH:36]=[C:35]([Cl:48])[C:34]=1[OH:49]>>[CH:14]1([C:12]([C:6]2[CH:7]=[N:8][C:9]3[C:4]([C:5]=2[NH:17][C:18]2[CH:23]=[CH:22][C:21]([CH2:24][N:25]4[CH2:26][CH2:27][N:28]([CH3:31])[CH2:29][CH2:30]4)=[CH:20][CH:19]=2)=[CH:3][C:2]([C:37]2[CH:38]=[C:33]([Cl:32])[C:34]([OH:49])=[C:35]([Cl:48])[CH:36]=2)=[CH:11][CH:10]=3)=[O:13])[CH2:15][CH2:16]1Participants
3
Procedure
Following general procedure D, {6-bromo-4-[4-((4-methylpiperazin-1-yl)methyl)phenylamino]quinolin-3-yl}(cyclopropyl)methanone (42 mg, 0.088 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (38 mg, 0.132 mmol) to afford the desired product (41 mg, 83%) as a yellow solid: 1H NMR (300 MHz, CD3OD) δ 9.27 (s, 1H), 7.93-7.85 (m, 2H), 7.74 (s, 1H), 7.37 (d, J=8.1 Hz, 2H), 7.19-7.10 (m, 4H), 3.61 (s, 2H), 2.95-2.88 (m, 1H), 2.74-2.68 (m, 4H), 2.57-2.46 (m, 7H), 1.23-1.10 (m, 4H); ESI MS m/z 561 [C31H30Cl2N4O2+H]+; HPLC 94.4% (AUC), tR=8.57 min.
Sources & evidence
- ORD record
- ord-cbb27805a9964c548e703065ae3a2eb0
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…